These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailability. Christiansen E; Due-Hansen ME; Urban C; Grundmann M; Schmidt J; Hansen SV; Hudson BD; Zaibi M; Markussen SB; Hagesaether E; Milligan G; Cawthorne MA; Kostenis E; Kassack MU; Ulven T J Med Chem; 2013 Feb; 56(3):982-92. PubMed ID: 23294321 [TBL] [Abstract][Full Text] [Related]
3. Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes. Bharate SB; Nemmani KV; Vishwakarma RA Expert Opin Ther Pat; 2009 Feb; 19(2):237-64. PubMed ID: 19441920 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and Structure-activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. Li Z; Qiu Q; Xu X; Wang X; Jiao L; Su X; Pan M; Huang W; Qian H Eur J Med Chem; 2016 May; 113():246-57. PubMed ID: 26945112 [TBL] [Abstract][Full Text] [Related]
5. Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties. Christiansen E; Urban C; Grundmann M; Due-Hansen ME; Hagesaether E; Schmidt J; Pardo L; Ullrich S; Kostenis E; Kassack M; Ulven T J Med Chem; 2011 Oct; 54(19):6691-703. PubMed ID: 21854074 [TBL] [Abstract][Full Text] [Related]
6. Novel free fatty acid receptor 1 (GPR40) agonists based on 1,3,4-thiadiazole-2-carboxamide scaffold. Krasavin M; Lukin A; Zhurilo N; Kovalenko A; Zahanich I; Zozulya S; Moore D; Tikhonova IG Bioorg Med Chem; 2016 Jul; 24(13):2954-2963. PubMed ID: 27229618 [TBL] [Abstract][Full Text] [Related]
7. Novel FFA1 (GPR40) agonists containing spirocyclic periphery: polar azine periphery as a driver of potency. Krasavin M; Lukin A; Bagnyukova D; Zhurilo N; Zahanich I; Zozulya S J Enzyme Inhib Med Chem; 2017 Dec; 32(1):29-36. PubMed ID: 27781494 [TBL] [Abstract][Full Text] [Related]
8. Continued SAR exploration of 1,2,4-thiadiazole-containing scaffolds in the design of free fatty acid receptor 1 (GPR40) agonists. Krasavin M; Lukin A; Bakholdina A; Zhurilo N; Onopchenko O; Borysko P; Zozulya S; Moore D; Tikhonova IG Eur J Med Chem; 2017 Nov; 140():229-238. PubMed ID: 28938138 [TBL] [Abstract][Full Text] [Related]
13. Discovery and development of CPL207280 as new GPR40/FFA1 agonist. Mach M; Bazydło-Guzenda K; Buda P; Matłoka M; Dzida R; Stelmach F; Gałązka K; Wąsińska-Kałwa M; Smuga D; Hołowińska D; Dawid U; Gurba-Bryśkiewicz L; Wiśniewski K; Dubiel K; Pieczykolan J; Wieczorek M Eur J Med Chem; 2021 Dec; 226():113810. PubMed ID: 34537444 [TBL] [Abstract][Full Text] [Related]
14. Discovery of phenylpropanoic acid derivatives containing polar functionalities as potent and orally bioavailable G protein-coupled receptor 40 agonists for the treatment of type 2 diabetes. Mikami S; Kitamura S; Negoro N; Sasaki S; Suzuki M; Tsujihata Y; Miyazaki T; Ito R; Suzuki N; Miyazaki J; Santou T; Kanzaki N; Funami M; Tanaka T; Yasuma T; Momose Y J Med Chem; 2012 Apr; 55(8):3756-76. PubMed ID: 22428944 [TBL] [Abstract][Full Text] [Related]
15. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats. Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists. Sasaki S; Kitamura S; Negoro N; Suzuki M; Tsujihata Y; Suzuki N; Santou T; Kanzaki N; Harada M; Tanaka Y; Kobayashi M; Tada N; Funami M; Tanaka T; Yamamoto Y; Fukatsu K; Yasuma T; Momose Y J Med Chem; 2011 Mar; 54(5):1365-78. PubMed ID: 21319751 [TBL] [Abstract][Full Text] [Related]
17. Structure-based optimization of free fatty acid receptor 1 agonists bearing thiazole scaffold. Li Z; Xu X; Hou J; Wang S; Jiang H; Zhang L Bioorg Chem; 2018 Apr; 77():429-435. PubMed ID: 29433092 [TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Development of GPR40 Modulators (FFA1/FFAR1): An Emerging Target for Type 2 Diabetes. Sharma N; Bhagat S; Chundawat TS Mini Rev Med Chem; 2017; 17(11):947-958. PubMed ID: 28117025 [TBL] [Abstract][Full Text] [Related]
19. Discovery of novel orally bioavailable GPR40 agonists. Lu H; Fei H; Yang F; Zheng S; Hu Q; Zhang L; Yuan J; Feng J; Sun P; Dong Q Bioorg Med Chem Lett; 2013 May; 23(10):2920-4. PubMed ID: 23582779 [TBL] [Abstract][Full Text] [Related]
20. [A New Pain Regulatory System via the Brain Long Chain Fatty Acid Receptor GPR40/FFA1 Signal]. Nakamoto K Yakugaku Zasshi; 2017; 137(2):199-204. PubMed ID: 28154332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]